Why the study?
Are PIMs/PPOs identified by the STOPP/START criteria clinically relevant in hip fracture patients?
Population
Hip fracture patients
Design
Other
Authors
Loading...
May support medication review in hip fracture patients with polypharmacy; leaves open impact on outcomes.
Are PIMs/PPOs identified by the STOPP/START criteria clinically relevant in hip fracture patients?
Approximately half of the potentially inappropriate medications and prescribing omissions identified by STOPP/START criteria in hip fracture patients are clinically relevant.
Lönnbro et al. (2017) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: